Fenofibrate-induced cirrhosis.

Suppr

超能文献

作者信息

Ahmed Furqaan, Petrovic Lydia, Rosen Ellen, Gonzalez Raimundo, Jacobson Ira M

出版信息

Dig Dis Sci. 2005 Feb;50(2):312-3. doi: 10.1007/s10620-005-1600-6.

DOI:10.1007/s10620-005-1600-6

PMID:15745090

Abstract

摘要

相似文献

Fenofibrate-induced cirrhosis.

Dig Dis Sci. 2005 Feb;50(2):312-3. doi: 10.1007/s10620-005-1600-6.

[Acute cytolytic and cholestatic hepatitis induced by fenofibrate].

Gastroenterol Clin Biol. 2003 Oct;27(10):947-9.

[Painful acute liver involvement related to ingestion of fenofibrate].

Gastroenterol Clin Biol. 1996;20(12):1137-8.

[Hepatitis caused by fenofibrate].

Cah Anesthesiol. 1986 May;34(3):249-50.

Fenofibrate monotherapy induced rhabdomyolysis.

Diabetes Care. 2003 Aug;26(8):2482-3. doi: 10.2337/diacare.26.8.2482.

Acute cholestatic hepatitis induced by fenofibrate.

J Clin Pharm Ther. 2009 Oct;34(5):599-602. doi: 10.1111/j.1365-2710.2009.01029.x.

The Association of Fenofibrate with Kidney Tubular Injury in a Subgroup of Participants in the ACCORD Trial.

Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1521-1523. doi: 10.2215/CJN.00370119. Epub 2019 Aug 13.

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.

Aliment Pharmacol Ther. 2011 Jan;33(2):235-42. doi: 10.1111/j.1365-2036.2010.04512.x. Epub 2010 Nov 17.

A case of lichenoid drug eruption induced by fenofibrate.

Eur J Dermatol. 2020 Jun 1;30(3):308-309. doi: 10.1684/ejd.2020.3780.

Acute renal failure due to fenofibrate monotherapy.

Anadolu Kardiyol Derg. 2011 Jun;11(4):371-2. doi: 10.5152/akd.2011.092. Epub 2011 May 18.

引用本文的文献

Liver injury caused by fenofibrate within 48 h after first administration: a case report.

BMC Gastroenterol. 2021 Jul 29;21(1):298. doi: 10.1186/s12876-021-01874-7.

本文引用的文献

[Acute hepatitis and drug dermatitis due to fenofibrate (Secalip)].

Ann Med Interne (Paris). 2001 Sep;152(5):353-4.

Liver fibrosis attributed to lipid lowering medications: two cases.

J Intern Med. 2001 Sep;250(3):249-54. doi: 10.1046/j.1365-2796.2001.00848.x.

The role of fibric acids in atherosclerosis.

Curr Atheroscler Rep. 2001 Jan;3(1):83-92. doi: 10.1007/s11883-001-0015-x.

Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.

Diabetes Metab. 2000 May;26(3):184-91.

[Acute severe fibrosing hepatitis associated with ciprofibrate treatment].

Gastroenterol Clin Biol. 1999 Dec;23(12):1399-400.

[Autoimmune hepatitis induced by fibrates].

Gastroenterol Clin Biol. 1998 May;22(5):525-9.

[Painful acute liver involvement related to ingestion of fenofibrate].

Gastroenterol Clin Biol. 1996;20(12):1137-8.

[Chronic active cirrhogenic hepatitis induced by fenofibrate].

Gastroenterol Clin Biol. 1993;17(8-9):612-3.

[Chronic active hepatitis associated with antinuclear antibodies induced by fenofibrate].

Gastroenterol Clin Biol. 1994;18(11):1048-9.

[Drug-induced hepatitis due to fenofibrate].

Therapie. 1980 May-Jun;35(3):403.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验